Clin2
NCT07876518Possibly a fitNot yet recruiting

Testing a new medicine for adults with overweight or obesity

Overweight and/or Obesity

Part of Hormones & metabolism clinical trials.

This study tests a new medicine called PF-08656795 to see how well it is tolerated and how it works in adults with overweight or obesity. It may help with weight management.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
150 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are an adult with a body mass index (BMI) between 25 and 40.
  • Your weight has been stable (not changing much) for at least 3 months before the study starts.
  • You are generally healthy, but you may have mild conditions like high cholesterol or high blood pressure.
  • You do not have any serious medical conditions affecting your blood, kidneys, hormones, lungs, stomach, heart, liver, brain, or allergies.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07595549Recruiting· Phase 3
Testing Berobenatide for Weight Loss in Overweight Adults

This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.

Canoga Park, California
NCT07731139Recruiting· Phase 1
Testing a new medicine for people with obesity

This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.

Lake Forest, California
NCT07725809Recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de
NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07845513Not yet recruiting· Phase 1
Study of a new weight-loss medicine in Chinese adults

This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.

Beijing, Beijing Municipality
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas

Hear when a new Overweight and/or Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.